Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Ten Kate

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 15, 2023
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's diseaseLiu Shi, Jin Xu, Rebecca Green, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Alzheimer'S Research & Therapy|August 5, 2018
The EMIF-AD PreclinAD study: study design and baseline cohort overviewElles Konijnenberg, Stephen F Carter, Mara Ten Kate, et al.
Computers in Biology and Medicine|May 18, 2024
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's diseaseAlicia Gómez-Pascual, Talel Naccache, Jin Xu, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 15, 2023
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's diseaseLiu Shi, Jin Xu, Rebecca Green, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Alzheimer'S Research & Therapy|August 5, 2018
The EMIF-AD PreclinAD study: study design and baseline cohort overviewElles Konijnenberg, Stephen F Carter, Mara Ten Kate, et al.
Computers in Biology and Medicine|May 18, 2024
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's diseaseAlicia Gómez-Pascual, Talel Naccache, Jin Xu, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Pageof 8